Amneal Pharmaceuticals (AMRX) Capital Expenditures (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Capital Expenditures of $8.2 million for Q1 2026, down 37.89% year-over-year from $13.2 million in Q1 2025, and down 62.45% quarter-over-quarter from $21.8 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Capital Expenditures (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Capital Expenditures history runs 10 years deep, the most recent figure standing at $8.2 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 37.89% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $65.1 million (up 16.44% YoY), while the FY2025 annual figure was $70.1 million, up 34.93% from the prior year.
- Capital Expenditures for Q1 2026 stood at $8.2 million, down from $21.8 million in the prior quarter.
- The five-year high for Capital Expenditures was $22.8 million in Q2 2025, with the low at $5.0 million in Q2 2022.
- The 5-year median for Capital Expenditures is $11.7 million (2023), against an average of $12.9 million.
- Peak annual rise in Capital Expenditures reached 137.73% in 2023, while the deepest fall reached 38.95% in 2023.
- Amneal Pharmaceuticals' Capital Expenditures stood at $11.5 million in 2022, then dropped by 13.96% to $9.9 million in 2023, then soared by 53.62% to $15.2 million in 2024, then jumped by 43.67% to $21.8 million in 2025, then slumped by 62.45% to $8.2 million in 2026.
- Business Quant data shows AMRX's Capital Expenditures at $8.2 million in Q1 2026, $21.8 million in Q4 2025, and $12.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.65 Bn | 39.99 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.33 Bn | 30.65 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.99 Bn | 19.32 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.74 Bn | 5.61 Bn | 334.51 Mn | 30.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.70 Mn |
| Jun 30, 2026 | 30.70 Mn |
| Mar 31, 2026 | 8.18 Mn |
| Mar 31, 2026 | 8.18 Mn |
| Dec 31, 2025 | 21.77 Mn |
| Dec 31, 2025 | 21.77 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Jun 30, 2025 | 22.83 Mn |
| Jun 30, 2025 | 22.83 Mn |
| Mar 31, 2025 | 13.16 Mn |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 15.16 Mn |
| Dec 31, 2024 | 15.16 Mn |
| Sep 30, 2024 | 16.95 Mn |
| Sep 30, 2024 | 16.95 Mn |
| Jun 30, 2024 | 10.63 Mn |
| Jun 30, 2024 | 10.63 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Mar 31, 2024 | 9.20 Mn |